Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UVXY vs GSK✓SelectedUSD · GSKUVXY vs GSK performance historyLatest closeAs of+22.46%11/20
Stock and ETF performance explorer

UVXY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-88.7%
GSK return
+53.4%
Excess return
-142.0%
Maximum drawdown
-94.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+22.5%-0.1%+22.6%+22.4%
7D+73.0%-5.3%+78.4%+67.6%
30D+85.3%-3.7%+89.0%+82.8%
3M+56.6%-7.3%+63.8%+50.8%
6M-8.7%-4.2%-4.5%-10.0%
YTD-13.4%+0.9%-14.2%-10.3%
1Y-52.6%+7.3%-59.9%-48.9%
3Y-88.7%+52.7%-141.4%-81.5%
All-88.7%+53.4%-142.0%-81.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling